Takeda launches value-based pricing program for lung cancer med Alunbrig, promises more deals to come

Takeda recently launched a value-based pricing program for its ALK lung cancer med Alunbrig in collaboration with Point32Health, a combination of Tufts Health Plan and Harvard Pilgrim Health Care covering 2 million people in the New England area.